Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Editing the fetal γ-globin promoters in hematopoietic stem cells from sickle cell disease patients induces therapeutic γ-globin levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 LRF-binding site disruption induces γ-globin expression in HUDEP-2 cells. (A) Schematic representation of the β-globin locus on chromosome 11, depicting the hypersensitive sites of the locus control region (white boxes) and the HBE1, HBG2, HBG1, HBD, and HBB genes (colored boxes). The sequence of the HBG2 and HBG1 identical promoters (from −210 to −100 nucleotides upstream of the HBG TSS) is shown below. Black arrows indicate HPFH mutations described at HBG1 and/or HBG2 promoters, with the percentage of HbF in heterozygous carriers of HPFH mutations (42). The highest HbF levels were generally observed in individuals carrying SCD (*) or β-thalassemia mutations (**). LRF- and BCL11A-binding sites [as described in (11)] are highlighted by orange and green boxes, respectively. The −114/−102 13-bp HPFH deletion is indicated by an empty box. Red arrows indicate the gRNA cleavage sites. (B to E) Globin expression analyses were performed in mature erythroblasts differentiated from Cas9-GFP+ HUDEP-2 cells. Results are shown as means ± SEM of three to four independent experiments. (B) RT-qPCR quantification of (Gγ + Aγ)- and β-globin transcripts. mRNA levels were expressed as percentage of (γ + β) globins, after normalization to α-globin mRNA levels. (C) Representative flow cytometry plots showing the percentage of HbF+ cells. (D) RP-HPLC analysis of globin chains. β-Like globin expression was normalized to α-globin. Representative RP-HPLC chromatograms are reported together with the expression of γ-globin chains (in brackets). The ratio of α chains to non–α chains was similar between HBG-edited and control samples. (E) ChIP-qPCR analysis of H3K27Ac at HBB and HBG promoters in −197-edited HUDEP-2 cells and control AAVS1–edited samples (day 5 of differentiation, n = 3). ChIP was performed using an antibody against H3K27Ac and the corresponding control immunoglobulin G (IgG). ****P ≤ 0.0001, ***P ≤ 0.001, **P ≤ 0.01, and *P ≤ 0.05 (unpaired t test). SSC, side scatter. (F) ChIP-qPCR analysis of LRF at HBG promoters in −197-edited and control AAVS1–edited K562 cells (n = 2 biologically independent experiments). ChIP was performed using an antibody against LRF. Two different primer pairs were used to amplify the HBG promoters (A and B). KLF1 and DEFB122 served as positive and negative controls, respectively.](https://figures.cochat.ai/paper-figures/2fc47826f09a43f2bc36ffa2fad643e4/editing-a-globin-repressor-binding-site-restores-fetal-hemoglobin-synthesis-and-figure-1.jpg)


![Fig. 4 Editing efficiency in repopulating HSPCs. (A) Engraftment of human cells in NSG mice transplanted with untreated (UT) and edited mobilized healthy donor CD34+ cells (n = 4 mice for each group) 16 weeks after transplantation. Engraftment is represented as percentage of human CD45+ cells in the total murine and human CD45+ cell population, in bone marrow (BM), spleen, thymus, and blood. Values shown are means ± SEM; *P ≤ 0.05 versus untreated [one-way analysis of variance (ANOVA)]. (B) Editing efficiency in the bone marrow– and spleen-derived human CD45+ progeny of repopulating HSPCs, as evaluated by Sanger sequencing and TIDE analysis. The proportion of edited alleles in the input HSPC populations (〇: HSPCs cultured for 6 days in “HSPC medium”; □: BFU-E; △: CFU-GM) is indicated (input). Values shown are means ± SEM. Each data point represents an individual mouse. (C) Genome editing efficiency in the input populations and in bone marrow– and spleen-derived human CD45+ populations edited with the −197, −196, or −115 gRNAs, as evaluated by Sanger sequencing and TIDE analysis. The main events associated with MH-motifs are indicated. Values shown are means ± SEM (n = 4 mice per group). ***P ≤ 0.001, **P ≤ 0.01, and *P ≤ 0.05 versus input (unpaired t test).](https://figures.cochat.ai/paper-figures/c685de666b35421eaf08718520f7cc06/editing-a-globin-repressor-binding-site-restores-fetal-hemoglobin-synthesis-and-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Disruption of BCL11A and ZBTB7A binding sites led to 30% to 40% g globin and 75% to 80% F-cells.27”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [27]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Natural mutations and clustered regulary interspaced short palindromic repeat (CRISPR)-Cas9 disruption of the BCL11A and ZBTB7A binding sites are associated with a large effect on expression of the g-globin genes.12,21,27”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Easy quantitative assessment of genome editing by sequence trace decomposition
Brinkman, E. K., Chen, T., Amendola, M., & van Steensel, B. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku936 · Cited by 2,390
Self-citationGUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268 · cited 8×
“Library preparation was performed using the original adapters and primers according to previous work (27).”
BackgroundMethodInfluentialHaeussler, M., Schönig, K., Eckert, H., Eschstruth, A., Mianné, J., Renaud, J.-B., Schneider-Maunoury, S., Shkumatava, A., Teboul, L., Kent, J., et al. (2016) · Genome biology · doi:10.1186/s13059-016-1012-2 · Cited by 1,756
Self-citationCRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Dever, D. P., Bak, R. O., Reinisch, A., Camarena, J., Washington, G., Nicolas, C. E., Pavel-Dinu, M., Saxena, N., Wilkens, A. B., Mantri, S., et al. (2016) · Nature · doi:10.1038/nature20134 · Cited by 864
Inference of CRISPR Edits from Sanger Trace Data
Conant, D., Hsiau, T., Rossi, N., Oki, J., Maures, T., Waite, K., Yang, J., Joshi, S., Kelso, R., Holden, K., et al. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0113 · Cited by 804
Gene therapy in a patient with sickle cell disease
Ribeil, J.-A., Hacein-Bey-Abina, S., Payen, E., Magnani, A., Semeraro, M., Magrin, E., Caccavelli, L., Neven, B., Bourget, P., El Nemer, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609677 · Cited by 696
Self-citationGene Therapy in Patients with Transfusion-Dependent β-Thalassemia
Thompson, A. A., Walters, M. C., Kwiatkowski, J., Rasko, J. E. J., Ribeil, J.-A., Hongeng, S., Magrin, E., Schiller, G. J., Payen, E., Semeraro, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705342 · Cited by 684
Self-citationEx vivo generation of fully mature human red blood cells from hematopoietic stem cells
Giarratana, M.-C., Kobari, L., Lapillonne, H., Chalmers, D., Kiger, L., Cynober, T., Marden, M. C., Wajcman, H., & Douay, L. (2005) · Nature Biotechnology · doi:10.1038/nbt1047 · Cited by 574
Targeted genome editing in human repopulating haematopoietic stem cells
Genovese, P., Schiroli, G., Escobar, G., Di Tomaso, T., Firrito, C., Calabria, A., Moi, D., Mazzieri, R., Bonini, C., Holmes, M. C., et al. (2014) · Nature · doi:10.1038/nature13420 · Cited by 555
Fetal hemoglobin in sickle cell anemia
Akinsheye, I., Alsultan, A., Solovieff, N., Ngo, D., Baldwin, C. T., Sebastiani, P., Chui, D. H. K., & Steinberg, M. H. (2011) · Blood · doi:10.1182/blood-2011-03-325258 · Cited by 553
Truong, L. N., Li, Y., Shi, L. Z., Hwang, P. Y.-H., He, J., Wang, H., Razavian, N., Berns, M. W., & Wu, X. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213431110 · Cited by 517
Highly efficient therapeutic gene editing of human hematopoietic stem cells
Wu, Y., Zeng, J., Roscoe, B. P., Liu, P., Yao, Q., Lazzarotto, C. R., Clement, K., Cole, M. A., Luk, K., Baricordi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0401-y · Cited by 515 · cited 9×
“Previous reports have suggested that HSCs, the target of therapeutic genome editing, are preferentially edited via the NHEJ mechanism (24, 25).”
BackgroundInfluentialDirect promoter repression by BCL11A controls the fetal to adult hemoglobin switch
Liu, N., Hargreaves, V. V., Zhu, Q., Kurland, J. V., Hong, J., Kim, W., Sher, F., Macias-Trevino, C., Rogers, J. M., Kurita, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.016 · Cited by 478
DeWitt, M. A., Magis, W., Bray, N. L., Wang, T., Berman, J. R., Urbinati, F., Heo, S.-J., Mitros, T., Muñoz, D. P., Boffelli, D., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf9336 · Cited by 477
Analyzing CRISPR genome-editing experiments with CRISPResso
Pinello, L., Canver, M. C., Hoban, M. D., Orkin, S. H., Kohn, D. B., Bauer, D. E., & Yuan, G.-C. (2016) · Nature Biotechnology · doi:10.1038/nbt.3583 · Cited by 459
Kurita, R., Suda, N., Sudo, K., Miharada, K., Hiroyama, T., Miyoshi, H., Tani, K., & Nakamura, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059890 · Cited by 418 · cited 1×
“HUDEP-2 cells (46) were cultured and differentiated, as previously described (47).”
MethodDNA sequence variation associated with elevated fetal G gamma globin production
Gilman, J., & Huisman, T. (1985) · Blood · doi:10.1182/blood.v66.4.783.783 · Cited by 373
Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin
Masuda, T., Wang, X., Maeda, M., Canver, M. C., Sher, F., Funnell, A. P. W., Fisher, C., Suciu, M., Martyn, G. E., Norton, L. J., et al. (2016) · Science · doi:10.1126/science.aad3312 · Cited by 373 · cited 2×
“However, knockdown of the transcriptional repressor LRF increases HbF expression but delays erythroid differentiation (28).”
BackgroundTraxler, E. A., Yao, Y., Wang, Y.-D., Woodard, K. J., Kurita, R., Nakamura, Y., Hughes, J. R., Hardison, R. C., Blobel, G. A., Li, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4170 · Cited by 366 · cited 3×
“This discrepancy between deletion efficiency in HUDEP-2 and HSPCs was also observed in previous studies targeting the −115 region (19, 22) and might be ascribed to a higher expression of the CRISPR-Cas9”
BackgroundMethodResultInfluentialStable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia
Walters, M. C., Patience, M., Leisenring, W., Rogers, Z. R., Aquino, V. M., Buchanan, G. R., Roberts, I. A. G., Yeager, A. M., Hsu, L., Adamkiewicz, T., et al. (2001) · Biology of Blood and Marrow Transplantation · doi:10.1053/bbmt.2001.v7.pm11787529 · Cited by 324
Martyn, G. E., Wienert, B., Yang, L., Shah, M., Norton, L. J., Burdach, J., Kurita, R., Nakamura, Y., Pearson, R. C. M., Funnell, A. P. W., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0085-0 · Cited by 300 · cited 5×
“An ideal and universal strategy to correct the clinical phenotype of patients with hemoglobinopathies would be to introduce HPFH mutations in the -globin promoters via homology-directed repair (11), which, however, is inefficient in HSCs (18).”
BackgroundMethodInfluentialInference of CRISPR Edits from Sanger Trace Data
Hsiau, T., Conant, D., Rossi, N., Maures, T., Waite, K., Yang, J., Joshi, S., Kelso, R., Holden, K., Enzmann, B. L., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/251082 · Cited by 295
Galarneau, G., Palmer, C. D., Sankaran, V. G., Orkin, S. H., Hirschhorn, J. N., & Lettre, G. (2010) · Nature Genetics · doi:10.1038/ng.707 · Cited by 269
Molecular Basis of Hereditary Persistence of Fetal Hemoglobin
FORGET, B. G. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10460.x · Cited by 268
Fetal hemoglobin in sickle cell anemia: a glass half full?
Steinberg, M. H., Chui, D. H. K., Dover, G. J., Sebastiani, P., & Alsultan, A. (2014) · Blood · doi:10.1182/blood-2013-09-528067 · Cited by 267
Marktel, S., Scaramuzza, S., Cicalese, M. P., Giglio, F., Galimberti, S., Lidonnici, M. R., Calbi, V., Assanelli, A., Bernardo, M. E., Rossi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0301-6 · Cited by 225
CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
Hoban, M. D., Lumaquin, D., Kuo, C. Y., Romero, Z., Long, J., Ho, M., Young, C. S., Mojadidi, M., Fitz-Gibbon, S., Cooper, A. R., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.148 · Cited by 220
Schiroli, G., Ferrari, S., Conway, A., Jacob, A., Capo, V., Albano, L., Plati, T., Castiello, M. C., Sanvito, F., Gennery, A. R., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan0820 · Cited by 214 · cited 1×
“To evaluate CRISPR-Cas9–mediated genetic modification of the CD34+ cell fraction containing more primitive HSPCs, HBG promoter editing was assessed in FACS-isolated HSPC subpopulations (26), after transfection of the −197 and −196 gRNAs, associated with high and low frequencies of deletions associated with MH motifs,…”
MethodInduction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus
Antoniani, C., Meneghini, V., Lattanzi, A., Felix, T., Romano, O., Magrin, E., Weber, L., Pavani, G., El Hoss, S., Kurita, R., et al. (2018) · Blood · doi:10.1182/blood-2017-10-811505 · Cited by 194
Self-citationMiccio, A., Cesari, R., Lotti, F., Rossi, C., Sanvito, F., Ponzoni, M., Routledge, S. J. E., Chow, C.-M., Antoniou, M. N., & Ferrari, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711666105 · Cited by 154
Self-citationCentis, F., Tabellini, L., Lucarelli, G., Buffi, O., Tonucci, P., Persini, B., Annibali, M., Emiliani, R., Iliescu, A., Rapa, S., et al. (2000) · Blood · doi:10.1182/blood.v96.10.3624 · Cited by 149
Beta‐thalassaemia intermedia: is it possible consistently to predict phenotype from genotype?
Ho, Hall, Luo, Weatherall, & Thein (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00519.x · Cited by 144
The -158 site 5' to the G gamma gene and G gamma expression
Labie, D., Dunda-Belkhodja, O., Rouabhi, F., Pagnier, J., Ragusa, A., & Nagel, R. (1985) · Blood · doi:10.1182/blood.v66.6.1463.1463 · Cited by 135
Lattanzi, A., Meneghini, V., Pavani, G., Amor, F., Ramadier, S., Felix, T., Antoniani, C., Masson, C., Alibeu, O., Lee, C., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2018.10.008 · Cited by 135
Self-citationWienert, B., Funnell, A. P. W., Norton, L. J., Pearson, R. C. M., Wilkinson-White, L. E., Lester, K., Vadolas, J., Porteus, M. H., Matthews, J. M., Quinlan, K. G. R., et al. (2015) · Nature Communications · doi:10.1038/ncomms8085 · Cited by 125
Gene Therapy for β-Hemoglobinopathies
Cavazzana, M., Antoniani, C., & Miccio, A. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.024 · Cited by 124
Self-citationThe effect of fetal hemoglobin on the survival characteristics of sickle cells
Franco, R. S., Yasin, Z., Palascak, M. B., Ciraolo, P., Joiner, C. H., & Rucknagel, D. L. (2006) · Blood · doi:10.1182/blood-2005-09-008318 · Cited by 119
Lagresle-Peyrou, C., Lefrère, F., Magrin, E., Ribeil, J.-A., Romano, O., Weber, L., Magnani, A., Sadek, H., Plantier, C., Gabrion, A., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.184788 · Cited by 117
Self-citationWake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies
Wienert, B., Martyn, G. E., Funnell, A. P. W., Quinlan, K. G. R., & Crossley, M. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.09.004 · Cited by 115
Association of thalassaemia intermedia with a beta‐globin gene haplotype
Thein, S. L., Wainscoat, J. S., Sampietro, M., Old, J. M., Cappellini, D., Fiorelli, G., Modell, B., & Weatherall, D. J. (1987) · British Journal of Haematology · doi:10.1111/j.1365-2141.1987.tb06870.x · Cited by 114
Editing the Genome Without Double-Stranded DNA Breaks
Komor, A. C., Badran, A. H., & Liu, D. R. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.7b00710 · Cited by 113
Humbert, O., Radtke, S., Samuelson, C., Carrillo, R. R., Perez, A. M., Reddy, S. S., Lux, C., Pattabhi, S., Schefter, L. E., Negre, O., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw3768 · Cited by 111
Abraham, A., Hsieh, M., Eapen, M., Fitzhugh, C., Carreras, J., Keesler, D., Guilcher, G., Kamani, N., Walters, M. C., Boelens, J. J., et al. (2017) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2017.08.038 · Cited by 109
KLF1 drives the expression of fetal hemoglobin in British HPFH
Wienert, B., Martyn, G. E., Kurita, R., Nakamura, Y., Quinlan, K. G. R., & Crossley, M. (2017) · Blood · doi:10.1182/blood-2017-02-767400 · Cited by 93
Li, C., Psatha, N., Sova, P., Gil, S., Wang, H., Kim, J., Kulkarni, C., Valensisi, C., Hawkins, R. D., Stamatoyannopoulos, G., et al. (2018) · Blood · doi:10.1182/blood-2018-03-838540 · Cited by 82
Open-source guideseq software for analysis of GUIDE-seq data
Tsai, S. Q., Topkar, V. V., Joung, J. K., & Aryee, M. J. (2016) · Nature Biotechnology · doi:10.1038/nbt.3534 · Cited by 78
Coquerelle, S., Ghardallou, M. E., Ali, S. R., Taupin, P., Touzot, F., Boquet, L., Blanche, S., Benaouadi, S., Brice, T., Tuchmann‐Durand, C., et al. (2019) · Human Gene Therapy · doi:10.1089/hum.2018.178 · Cited by 54
Self-citationLux, C. T., Pattabhi, S., Berger, M. P., Nourigat, C., Flowers, D. A., Nègre, O., Humbert, O., Yang, J., Lee, C., Jacoby, K., et al. (2018) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.12.008 · Cited by 53
The regulation of human globin promoters by CCAAT box elements and the recruitment of NF-Y
Martyn, G. E., Quinlan, K. G. R., & Crossley, M. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.10.002 · Cited by 41
Altrock, P. M., Brendel, C., Renella, R., Orkin, S. H., Williams, D. A., & Michor, F. (2016) · American Journal of Hematology · doi:10.1002/ajh.24449 · Cited by 30
Romano, O., Peano, C., Tagliazucchi, G. M., Petiti, L., Poletti, V., Cocchiarella, F., Rizzi, E., Severgnini, M., Cavazza, A., Rossi, C., et al. (2016) · Scientific Reports · doi:10.1038/srep24724 · Cited by 24
Self-citationOutcomes for Initial Patient Cohorts with up to 33 Months of Follow-up in the Hgb-206 Phase 1 Trial
Kanter, J., Tisdale, J. F., Kwiatkowski, J. L., Krishnamurti, L., Mapara, M. Y., Schmidt, M., Miller, A. L., Pierciey, F. J., Shi, W., Ribeil, J., et al. (2018) · Blood · doi:10.1182/blood-2018-99-113477 · Cited by 15
Analysis of RBC Properties in Patients with SCD Treated with Lentiglobin Gene Therapy
Hebert, N., Magrin, E., Miccio, A., Kiger, L., Nguyen, K., Joseph, L., Magnani, A., Couzin, C., Nemer, W. E., Pirenne, F., et al. (2018) · Blood · doi:10.1182/blood-2018-99-115973 · Cited by 5
Self-citation
Research works printed but not linked: 1
- 10.1016/j.ymthe.2018.10.008 · DOI · Paper page
Cited by
Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
Leibowitz, M. L., Papathanasiou, S., Doerfler, P. A., Blaine, L. J., Sun, L., Yao, Y., Zhang, C.-Z., Weiss, M. J., & Pellman, D. (2021) · Nature Genetics · doi:10.1038/s41588-021-00838-7 · Cited by 583
Gene therapy using haematopoietic stem and progenitor cells
Ferrari, G., Thrasher, A. J., & Aiuti, A. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-00298-5 · Cited by 254
Global marine microbial diversity and its potential in bioprospecting
Chen, J., Jia, Y., Sun, Y., Liu, K., Zhou, C., Liu, C., Li, D., Liu, G., Zhang, C., Yang, T., et al. (2024) · Nature · doi:10.1038/s41586-024-07891-2 · Cited by 190
Piel, F. B., Rees, D. C., DeBaun, M. R., Nnodu, O., Ranque, B., Thompson, A. A., Ware, R. E., Abboud, M. R., Abraham, A., Ambrose, E. E., et al. (2023) · The Lancet Haematology · doi:10.1016/s2352-3026(23)00096-0 · Cited by 177
Fetal hemoglobin in sickle cell anemia
Steinberg, M. H. (2020) · Blood · doi:10.1182/blood.2020007645 · Cited by 136
Metadata
- Authors
- Weber, L., Frati, G., Felix, T., Hardouin, G., Casini, A., Wollenschlaeger, C., Meneghini, V., Masson, C., De Cian, A., Chalumeau, A., Mavilio, F., Amendola, M., Andre-Schmutz, I., Cereseto, A., El Nemer, W., Concordet, J.-P., Giovannangeli, C., Cavazzana, M., & Miccio, A.
- Affiliations
- Inserm (FR)
- Laboratory of chromatin and gene regulation during development, INSERM UMR1163, Paris, France.
- University of Trento (IT)
- Paris-Descartes Bioinformatics Platform, Imagine Institute, Paris 75015, France.
- INSERM U1154, CNRS UMR7196, Museum National d’Histoire Naturelle, Paris, France.
- University of Modena and Reggio Emilia (IT)
- Laboratory of Human Lymphohematopoiesis, INSERM UMR1163, Paris, France.
- Biologie Intégrée du Globule Rouge UMR_S1134, Inserm, Univ. Paris Diderot, Sorbonne Paris Cité, Univ. de la Réunion, Univ. des Antilles, Paris, France.
- Centre National de la Recherche Scientifique (FR)
- Hôpital Necker-Enfants Malades (FR)
- Corresponding author
- Weber, Leslie
- Frati, Giacomo
- Miccio, Annarita
- ORCID
- Venue
- Science Advances
- Published
- 2020-02-14
- Volume
- 6
- Issue
- 7
- Pages
- eaay9392
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC7015694
- OpenAlex
- W3006567544
- Semantic Scholar
- 52b26144b0ee0a8db71bd718acdc5bf17daaa068
- Cited by
- 140
- References
- 53
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 20 · 2023: 26 · 2022: 19 · 2021: 30 · 2020: 15
- FWCI
- 11.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by-nc)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, cc-by-nc)
- Institutional Research Information System (Università degli Studi di Trento) (submittedVersion, cc-by-nc)
- HAL (submittedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- European Research Council
- Agence Nationale de la Recherche
- Genopole
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- sickle cell disease, fetal hemoglobin, CRISPR/Cas9 genome editing, hematopoietic stem and progenitor cells, xenotransplantation, promoter editing
- MeSH terms
- Gene Editing, Anemia, Sickle Cell, Binding Sites, Fetal Hemoglobin, Humans, Phenotype, beta-Thalassemia, beta-Globins, gamma-Globins, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.